Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Ovarian cancer doesn’t have a single known cause, but several factors can raise or lower your risk. If you have a family history of ovarian cancer or an inherited gene mutation such as BRCA1 or BRCA2, there are some ways to lower your risk or help prevent certain types of ovarian cancer.
The exact cause of most ovarian cancers is not known, but researchers have found several factors that can affect the risk of epithelial ovarian cancer. These include:
Much less is known about risk factors for germ cell and stromal tumors of the ovaries.
Researchers have made great progress in understanding how certain gene mutations (changes) can cause normal cells to become cancerous. For example, some genes contain instructions for controlling when our cells grow and divide. Mutations in these genes can lead to the development of cancer.
Scientists are also learning more about how these genes work when they’re healthy—and how disrupting their function can lead to cancer. This research is expected to lead to new drugs for preventing and treating familial ovarian cancer in the future.
A small portion of ovarian cancers occur in women with inherited mutations that increase cancer risk. These mutations can be passed down through families and some are linked to certain cancer syndromes.
Mutations linked to a higher risk of ovarian cancer include:
Genetic testing can detect these inherited mutations. If you have a family history of cancers linked to these syndromes, such as breast and ovarian cancer, thyroid and ovarian cancer, or colorectal and endometrial (uterine) cancer, ask your doctor about genetic counseling and testing.
The American Cancer Society recommends discussing genetic testing with a qualified cancer genetics professional before any genetic testing is done. For more, see Genetics and Cancer.
Research in this area has already led to better ways to detect high-risk genes and estimate a person’s ovarian cancer risk. A better understanding of how genetic and hormonal factors (such as oral contraceptive use) interact may also lead to new ways to prevent ovarian cancer.
Most gene mutations related to ovarian cancer are not inherited. Instead, they occur during a person’s life and are called acquired mutations. In some cancers, these mutations may be caused by radiation or harmful chemicals, but there is no evidence for this in ovarian cancer. So far, no specific chemical in the environment or in our diets has been clearly linked to mutations that cause ovarian cancer. In most cases, the cause of these acquired mutations is still unknown.
Most ovarian cancers have several acquired mutations. Tests can identify some of these, such as changes in the TP53 tumor suppressor gene or the HER2 oncogene. More research is needed to understand whether this information could help predict a person’s prognosis.
It usually takes several gene mutations over time for normal cells to become cancer. Researchers are still studying why these changes happen. Here are some reasons why this might happen in ovarian cancer:
Most women have one or more risk factors for ovarian cancer, but most of these only slightly increase risk. They don’t fully explain why ovarian cancer is relatively common. So far, knowing about these risk factors hasn’t led to practical ways to prevent ovarian cancer.
If you are concerned about your risk of ovarian cancer, talk to your health care team. They can help you understand your risk and explore possible ways to lower it.
There are several ways to reduce your risk of developing the most common type of ovarian cancer, epithelial ovarian cancer, including certain procedures and lifestyle choices such as:
Much less is known about ways to lower the risk of developing germ cell and stromal tumors of the ovaries, so this information does not apply to those types.
Learn more: Ovarian Cancer Risk Factors
If your family history suggests that you or a close relative might have a syndrome linked with a high risk of ovarian cancer, consider genetic counseling and testing. Genetic counseling involves reviewing your personal medical and family history and is done by a genetic counselor or other health care professional. This can help predict whether you are likely to have one of the gene mutations associated with an increased ovarian cancer risk.
The counselor will also discuss the benefits and potential drawbacks of genetic testing with you. Genetic testing can help determine if you or members of your family carry certain gene mutations that cause a high risk of ovarian cancer. However, the results are not always clear, and a genetic counselor can help you sort out what the results mean to you.
Knowing that you have a mutation such as BRCA1 or BRCA2 can be very helpful in making important decisions about certain prevention strategies for yourself and your children.
These prevention strategies include:
If you are considering surgery, mathematical models can help estimate how many years of life an average person with a BRCA mutation might gain by having both ovaries and fallopian tubes removed before cancer starts. Although these tools can predict average outcomes for large groups, they cannot predict what will happen for any one person.
Removing the ovaries can also lower the risk of breast cancer for premenopausal women with BRCA gene mutations. The risk of ovarian cancer is reduced by 85% to 95%, and the risk of breast cancer cut by 50% or more.
Many experts now believe that some ovarian cancers (especially high-grade serous carcinomas) and many primary peritoneal cancers actually start in the fallopian tubes. According to this theory, early cancer cells can form in the fallopian tubes, break away, and attach to the surface of the ovaries or peritoneum. Once in these new places, the cancer cells may grow more quickly.
This idea could affect surgical options for preventing ovarian cancer. Some people at high risk may have the option to remove only their fallopian tubes at first. The ovaries could then be removed later. This approach may help avoid or delay problems caused by the loss of estrogen from the ovaries, such as bone loss, heart disease, and menopause symptoms.
Researchers are studying whether this 2-step approach is an effective way to prevent ovarian cancer. However, it’s not likely to lower breast cancer risk as much removing the ovaries earlier.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention. Obstet Gynecol 2019;133:e279-e284; statement: https://www.sgo.org/resources/sgo-clinical-practice-statement-salpingectomy-for-ovarian-cancer-prevention
Falconer H, Yin L, Grönberg H, Altman D. Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst 2015;107:dju410 Cannistra SA, Gershenson DM, Recht A. Ch 76 - Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2015.
Gaba F, Goyal S, Marks D, et al; PROTECTOR team. Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy salpingo-oophorectomy: a qualitative study. J Med Genet 2022;59:122-132.
Hanley GE, Pearce CL, Talhouk A, et al. Outcomes from opportunistic salpingectomy for ovarian cancer prevention. JAMA Netw Open 2022; 5:1-10.
Morgan M, Boyd J, Drapkin R, Seiden MV. Ch 89 – Cancers Arising in the Ovary. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, Kastan MB, McKenna WG, eds. Clinical Oncology. 5th ed. Philadelphia, PA: Elsevier; 2014: 1592.
Last Revised: August 8, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.